Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Double-Blind, Placebo-Controlled Study of the Safety and Preliminary Effectiveness of MTS-01 for the Prevention of Alopecia Induced by Whole Brain Radiotherapy

NCT00801086 is registered in ClinicalTrials.gov with Mitos Pharmaceuticals as lead sponsor.

NCT NCT00801086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00801086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Double-Blind, Placebo-Controlled Study of the Safety and Preliminary Effectiveness of MTS-01 for the Prevention of Alopecia Induced by Whole Brain Radiotherapy
Lead sponsor
Mitos Pharmaceuticals
Phase
Phase 2
Overall status
Unknown status
Start date
November 30, 2008
Completion date
June 30, 2010
Enrollment
16 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alopecia